Click for best price
Ovarian Cancer Therapeutics Market Size, Share 2022
Ovarian cancer, and its rising incidence rate, is a growing concern worldwide. Market players that are currently engaged in the development of drugs and therapies for ovarian cancer stand to benefit by observing the latest trends and pipeline competitor products.
This report contains market size and forecasts of Ovarian Cancer Therapeutics in Global, including the following market information:
Global Ovarian Cancer Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Ovarian Cancer Therapeutics market was valued at 1815.3 million in 2021 and is projected to reach US$ 2580.9 million by 2028, at a CAGR of 5.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PARP Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ovarian Cancer Therapeutics include Bristol Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Janssen Pharmaceuticals, Genentech Inc., Astra Zeneca, Boehringer Ingelheim GmbH and Hoffmann La Roche Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ovarian Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ovarian Cancer Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Ovarian Cancer Therapeutics Market Segment Percentages, by Type, 2021 (%)
PARP
PD-L1
Angiogenesis Inhibitors
Global Ovarian Cancer Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Ovarian Cancer Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hosptial
Research
Global Ovarian Cancer Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Ovarian Cancer Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ovarian Cancer Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Ovarian Cancer Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol Myers Squibb Company
Eli Lilly and Company
GlaxoSmithKline Plc
Janssen Pharmaceuticals
Genentech Inc.
Astra Zeneca
Boehringer Ingelheim GmbH
Hoffmann La Roche Ltd.
| Report Attributes |
Report Details |
| Report Title |
Ovarian Cancer Therapeutics Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
69 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Ovarian Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ovarian Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ovarian Cancer Therapeutics Overall Market Size
2.1 Global Ovarian Cancer Therapeutics Market Size: 2021 VS 2028
2.2 Global Ovarian Cancer Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Ovarian Cancer Therapeutics Players in Global Market
3.2 Top Global Ovarian Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Ovarian Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Ovarian Cancer Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Ovarian Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ovarian Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Ovarian Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Ovarian Cancer Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Ovarian Cancer Therapeutics Market Size Markets, 2021 & 2028
4.1.2 PARP
4.1.3 PD-L1
4.1.4 Angiogenesis Inhibitors
4.2 By Type - Global Ovarian Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Ovarian Cancer Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Ovarian Cancer Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Ovarian Cancer Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ovarian Cancer Therapeutics Market Size, 2021 & 2028
5.1.2 Hosptial
5.1.3 Research
5.2 By Application - Global Ovarian Cancer Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Ovarian Cancer Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Ovarian Cancer Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Ovarian Cancer Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Ovarian Cancer Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Ovarian Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Ovarian Cancer Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Ovarian Cancer Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Ovarian Cancer Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Ovarian Cancer Therapeutics Revenue, 2017-2028
6.3.2 US Ovarian Cancer Therapeutics Market Size, 2017-2028
6.3.3 Canada Ovarian Cancer Therapeutics Market Size, 2017-2028
6.3.4 Mexico Ovarian Cancer Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Ovarian Cancer Therapeutics Revenue, 2017-2028
6.4.2 Germany Ovarian Cancer Therapeutics Market Size, 2017-2028
6.4.3 France Ovarian Cancer Therapeutics Market Size, 2017-2028
6.4.4 U.K. Ovarian Cancer Therapeutics Market Size, 2017-2028
6.4.5 Italy Ovarian Cancer Therapeutics Market Size, 2017-2028
6.4.6 Russia Ovarian Cancer Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Ovarian Cancer Therapeutics Market Size, 2017-2028
6.4.8 Benelux Ovarian Cancer Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Ovarian Cancer Therapeutics Revenue, 2017-2028
6.5.2 China Ovarian Cancer Therapeutics Market Size, 2017-2028
6.5.3 Japan Ovarian Cancer Therapeutics Market Size, 2017-2028
6.5.4 South Korea Ovarian Cancer Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Ovarian Cancer Therapeutics Market Size, 2017-2028
6.5.6 India Ovarian Cancer Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Ovarian Cancer Therapeutics Revenue, 2017-2028
6.6.2 Brazil Ovarian Cancer Therapeutics Market Size, 2017-2028
6.6.3 Argentina Ovarian Cancer Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Ovarian Cancer Therapeutics Revenue, 2017-2028
6.7.2 Turkey Ovarian Cancer Therapeutics Market Size, 2017-2028
6.7.3 Israel Ovarian Cancer Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Ovarian Cancer Therapeutics Market Size, 2017-2028
6.7.5 UAE Ovarian Cancer Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Bristol Myers Squibb Company
7.1.1 Bristol Myers Squibb Company Corporate Summary
7.1.2 Bristol Myers Squibb Company Business Overview
7.1.3 Bristol Myers Squibb Company Ovarian Cancer Therapeutics Major Product Offerings
7.1.4 Bristol Myers Squibb Company Ovarian Cancer Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Bristol Myers Squibb Company Key News
7.2 Eli Lilly and Company
7.2.1 Eli Lilly and Company Corporate Summary
7.2.2 Eli Lilly and Company Business Overview
7.2.3 Eli Lilly and Company Ovarian Cancer Therapeutics Major Product Offerings
7.2.4 Eli Lilly and Company Ovarian Cancer Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Eli Lilly and Company Key News
7.3 GlaxoSmithKline Plc
7.3.1 GlaxoSmithKline Plc Corporate Summary
7.3.2 GlaxoSmithKline Plc Business Overview
7.3.3 GlaxoSmithKline Plc Ovarian Cancer Therapeutics Major Product Offerings
7.3.4 GlaxoSmithKline Plc Ovarian Cancer Therapeutics Revenue in Global Market (2017-2022)
7.3.5 GlaxoSmithKline Plc Key News
7.4 Janssen Pharmaceuticals
7.4.1 Janssen Pharmaceuticals Corporate Summary
7.4.2 Janssen Pharmaceuticals Business Overview
7.4.3 Janssen Pharmaceuticals Ovarian Cancer Therapeutics Major Product Offerings
7.4.4 Janssen Pharmaceuticals Ovarian Cancer Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Janssen Pharmaceuticals Key News
7.5 Genentech Inc.
7.5.1 Genentech Inc. Corporate Summary
7.5.2 Genentech Inc. Business Overview
7.5.3 Genentech Inc. Ovarian Cancer Therapeutics Major Product Offerings
7.5.4 Genentech Inc. Ovarian Cancer Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Genentech Inc. Key News
7.6 Astra Zeneca
7.6.1 Astra Zeneca Corporate Summary
7.6.2 Astra Zeneca Business Overview
7.6.3 Astra Zeneca Ovarian Cancer Therapeutics Major Product Offerings
7.6.4 Astra Zeneca Ovarian Cancer Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Astra Zeneca Key News
7.7 Boehringer Ingelheim GmbH
7.7.1 Boehringer Ingelheim GmbH Corporate Summary
7.7.2 Boehringer Ingelheim GmbH Business Overview
7.7.3 Boehringer Ingelheim GmbH Ovarian Cancer Therapeutics Major Product Offerings
7.7.4 Boehringer Ingelheim GmbH Ovarian Cancer Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Boehringer Ingelheim GmbH Key News
7.8 Hoffmann La Roche Ltd.
7.8.1 Hoffmann La Roche Ltd. Corporate Summary
7.8.2 Hoffmann La Roche Ltd. Business Overview
7.8.3 Hoffmann La Roche Ltd. Ovarian Cancer Therapeutics Major Product Offerings
7.8.4 Hoffmann La Roche Ltd. Ovarian Cancer Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Hoffmann La Roche Ltd. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Ovarian Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Ovarian Cancer Therapeutics Market Drivers in Global Market
Table 3. Ovarian Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Ovarian Cancer Therapeutics in Global Market
Table 5. Top Ovarian Cancer Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Ovarian Cancer Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Ovarian Cancer Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Ovarian Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Ovarian Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ovarian Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Ovarian Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Ovarian Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Ovarian Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Ovarian Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Ovarian Cancer Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Ovarian Cancer Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Bristol Myers Squibb Company Corporate Summary
Table 31. Bristol Myers Squibb Company Ovarian Cancer Therapeutics Product Offerings
Table 32. Bristol Myers Squibb Company Ovarian Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Eli Lilly and Company Corporate Summary
Table 34. Eli Lilly and Company Ovarian Cancer Therapeutics Product Offerings
Table 35. Eli Lilly and Company Ovarian Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline Plc Corporate Summary
Table 37. GlaxoSmithKline Plc Ovarian Cancer Therapeutics Product Offerings
Table 38. GlaxoSmithKline Plc Ovarian Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Janssen Pharmaceuticals Corporate Summary
Table 40. Janssen Pharmaceuticals Ovarian Cancer Therapeutics Product Offerings
Table 41. Janssen Pharmaceuticals Ovarian Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Genentech Inc. Corporate Summary
Table 43. Genentech Inc. Ovarian Cancer Therapeutics Product Offerings
Table 44. Genentech Inc. Ovarian Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Astra Zeneca Corporate Summary
Table 46. Astra Zeneca Ovarian Cancer Therapeutics Product Offerings
Table 47. Astra Zeneca Ovarian Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Boehringer Ingelheim GmbH Corporate Summary
Table 49. Boehringer Ingelheim GmbH Ovarian Cancer Therapeutics Product Offerings
Table 50. Boehringer Ingelheim GmbH Ovarian Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Hoffmann La Roche Ltd. Corporate Summary
Table 52. Hoffmann La Roche Ltd. Ovarian Cancer Therapeutics Product Offerings
Table 53. Hoffmann La Roche Ltd. Ovarian Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Ovarian Cancer Therapeutics Segment by Type in 2021
Figure 2. Ovarian Cancer Therapeutics Segment by Application in 2021
Figure 3. Global Ovarian Cancer Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Ovarian Cancer Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Ovarian Cancer Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ovarian Cancer Therapeutics Revenue in 2021
Figure 8. By Type - Global Ovarian Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Ovarian Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Ovarian Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Ovarian Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Ovarian Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Ovarian Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Ovarian Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Ovarian Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Ovarian Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Bristol Myers Squibb Company Ovarian Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eli Lilly and Company Ovarian Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline Plc Ovarian Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Janssen Pharmaceuticals Ovarian Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Genentech Inc. Ovarian Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Astra Zeneca Ovarian Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Boehringer Ingelheim GmbH Ovarian Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Hoffmann La Roche Ltd. Ovarian Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
